1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid) has been researched along with yttrium radioisotopes in 1 studies
Studies (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid)) | Trials (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid)) | Recent Studies (post-2010) (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid)) | Studies (yttrium radioisotopes) | Trials (yttrium radioisotopes) | Recent Studies (post-2010) (yttrium radioisotopes) |
---|---|---|---|---|---|
25 | 4 | 8 | 3,407 | 339 | 1,533 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arani, SS; Maraghe, MG; Mehrabi, M; Salek, N; Samani, AB; Vosoghi, S | 1 |
1 other study(ies) available for 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid) and yttrium radioisotopes
Article | Year |
---|---|
Preparation and Dosimetry Evaluation of a Carrier- Free 90Y Labeled DOTMP as a Promising Agent for Bone Marrow Ablation.
Topics: Ablation Techniques; Animals; Bone Marrow; Femur; Lutetium; Mice; Models, Biological; Organophosphorus Compounds; Radiation Dosage; Radioisotopes; Rats, Wistar; Samarium; Tissue Distribution; Yttrium Radioisotopes | 2018 |